About
Small Molecules, Diagnostics
Areas of Focus
Categories
DiagnosticsNon-PharmaceuticalSmall Molecule Pharmaceutical
Clinical Trials (18)
View allTotal Trials
18
As Lead Sponsor
17
As Collaborator
1
Total Enrollment
3,591
By Phase
PHASE3: 8PHASE1: 2PHASE2: 6PHASE2/PHASE3: 1
By Status
COMPLETED: 14ENROLLING_BY_INVITATION: 1RECRUITING: 1TERMINATED: 1WITHDRAWN: 1
Clinical Trials Pipeline18 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT05962788Lead Sponsor
Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis
PHASE3Enrolling by invitation
40 participants
Started: Mar 27, 2024 · Completed: Jun 30, 2029
NCT05288855Lead Sponsor
Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis
PHASE3Recruiting
40 participants
Started: Oct 10, 2023 · Completed: Jun 30, 2028
NCT05337124Lead Sponsor
A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
N/ACompleted
229 participants
Started: Apr 5, 2022 · Completed: Jan 31, 2025
NCT05306379Lead Sponsor
Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin
PHASE1Completed
24 participants
Started: Jan 24, 2022 · Completed: Apr 5, 2022
NCT04701528Collaborator
Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients
PHASE2Completed
20 participants
Started: Nov 15, 2020 · Completed: Oct 25, 2022
Locations (1)
Headquarters
Edmonton, AB, Canada
Map
Loading map...